The Morehouse School of Medicine, one of four historically Black medical schools in the country, has established a new partnership with Manifold, an AI-powered clinical data platform, to enhance research initiatives at the school’s Institute of Translational Genomic Medicine.
By leveraging Manifold’s technology, scholars at the Institute of Translational Genomic Medicine will work to build their own modern data foundation for cancer research through utilizing AI-powered analysis capabilities to integrate diverse data types in a unified platform.
The institute plans to first focus their new capabilities on advancing research for a cohort of breast cancer patients of African ancestry enrolled in a study at the New York Genome Center. The project aims to better understand how cancer manifests in underrepresented populations by uncovering detailed insights on the molecular attributes of cancer in their communities.
“Connecting this data represents a transformative shift in how we understand cancer disparities and accelerates the progress we can achieve as a community,” said Dr. Melissa Davis, director of the Institute of Translational Genomic Medicine. “Manifold’s partnership helps us advance our mission to provide genomic research capacity across MSM as well as to increase knowledge of genetic variation across the African diaspora and its impact on health and disease.”
